1. Abboud, R.T., Chalmers, A., Gofton, J.P., Richter, A.M., Enarson, D.A. Relationship between severity of rheumatoid arthritis and serum alpha-1-antitrypsin. J Rheumatol 1991, 18, 1490–1495.
2. Arnet, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, H.S., Medsper, T.A., Mithchel D.M., Neustadt, D.H., Pinals, R.S., Schaller, J.G., Sharp, J.T., Wilder, R.L., Hunder, G.G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31, 315–324.
3. Boerbooms, A.M., Jeurissen, M.E., Westgeest, A.A., Theunisse, H., Van-de-Putte, L.B. Methotrexate in refractory rheumatoid arthritis. Clin Rheumatol 1988, 7, 249–256.
4. Bog-Hansen, T.C. Crossed immuno-affinoelectrophoresis Anal Biochem 1973, 56, 480–488.
5. Bowen, M., Rayses, J.G., Cooper, E.H., Glass, M. Changes in the relative amount of individual microheterogenous forms of serum alpha-1-antichymotrypsin in disease. In: Lectins, Vol II. Ed.: Bog-Hansen, T.C., Berlin de Gruyter 1992, 403–441.